Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Thiazoles/adverse effects"'
Publikováno v:
Acta Médica Portuguesa (2024)
N/a.
Externí odkaz:
https://doaj.org/article/8bc6d44b7ff145b59406ed78337e89ac
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Contact Dermatitis, Vol. 81, No 2 (2019) pp. 140-141
1,2-Benzisothiazolin-3-one (BIT) is an antimicrobial agent that is widely used as a preservative in non-cosmetic products. It has been recognized as an allergen since 1976, and has been shown to be responsible for occupational contact dermatitis in w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4d497b8a13dd3ed7b5277b3462ed6a3
https://doi.org/10.1111/cod.13261
https://doi.org/10.1111/cod.13261
Publikováno v:
Contact Dermatitis, Vol. 80, No 6 (2019) pp. 407-408
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c723928ceee5724de648015fb87601c
https://doi.org/10.1111/cod.13230
https://doi.org/10.1111/cod.13230
Publikováno v:
Madsen, J T & Andersen, K E 2016, ' Contact allergy to 1,2-benzisothiazolin-3-one ', Contact Dermatitis, vol. 75, no. 5, pp. 324-326 . https://doi.org/10.1111/cod.12570
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daf24c04034e19b51adfc10a13959dab
https://pubmed.ncbi.nlm.nih.gov/27709698
https://pubmed.ncbi.nlm.nih.gov/27709698
Autor:
Denis Ouzan, Shuhei Nishiguchi, Anne-Marie Quinson, George Kukolj, Jerry O. Stern, Christophe Moreno, Joseph Scherer, M. V. Maevskaya, L. Morano, Filipe Calinas, Peter Ferenci, Masao Omata, Kosh Agarwal, Graham R. Foster, Yakov Datsenko, Jean-François Dufour, Marc Bourlière, Elmar Zehnter, Stefan Zeuzem, Javier Crespo, Miguel Garcia, Daniel M. Forton, Tarik Asselah, Marcus Schuchmann, Christoph Sarrazin
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Ferenci, Peter; Asselah, Tarik; Foster, Graham R; Zeuzem, Stefan; Sarrazin, Christoph; Moreno, Christophe; Ouzan, Denis; Maevskaya, Marina; Calinas, Filipe; Morano, Luis E; Crespo, Javier; Dufour, Jean-François; Bourlière, Marc; Agarwal, Kosh; Forton, Daniel; Schuchmann, Marcus; Zehnter, Elmar; Nishiguchi, Shuhei; Omata, Masao; Kukolj, George; ... (2015). STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection. Journal of hepatology, 62(6), pp. 1246-1255. Elsevier 10.1016/j.jhep.2014.12.024
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Ferenci, Peter; Asselah, Tarik; Foster, Graham R; Zeuzem, Stefan; Sarrazin, Christoph; Moreno, Christophe; Ouzan, Denis; Maevskaya, Marina; Calinas, Filipe; Morano, Luis E; Crespo, Javier; Dufour, Jean-François; Bourlière, Marc; Agarwal, Kosh; Forton, Daniel; Schuchmann, Marcus; Zehnter, Elmar; Nishiguchi, Shuhei; Omata, Masao; Kukolj, George; ... (2015). STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection. Journal of hepatology, 62(6), pp. 1246-1255. Elsevier 10.1016/j.jhep.2014.12.024
BACKGROUND & AIMS The efficacy and tolerability of faldaprevir, a potent hepatitis C virus (HCV) NS3/4A protease inhibitor, plus peginterferon and ribavirin was assessed in a double-blind, placebo-controlled phase 3 study of treatment-naïve patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48feb1ddd3b1a0089ca2b28b5256ec41
Publikováno v:
Pediatric Dermatology, Vol. 32, No 3 (2015) pp. e86-88
Isothiazolinone is known to be a sensitizer and a frequent cause of contact dermatitis in adults. Cases of contact dermatitis have also recently been reported in children. Derivatives of isothiazolinone, such as methylisothiazolinone (MI) and methylc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::210c80ffec86ea0ce65367e914f52e8a
https://pubmed.ncbi.nlm.nih.gov/25775929
https://pubmed.ncbi.nlm.nih.gov/25775929
Autor:
L. Hantson, CL Franke, Robert Woestenborghs, Luc Tritsmans, Rlla Schellens, J. Gheuens, de Jacques Keyser, J van Gorp, A. Van Peer, Van de Velde
Publikováno v:
Clinical Therapeutics, 19(6), 1340-1351. Elsevier
A total of 22 patients with acute ischemic stroke participated in two randomized, single-masked, placebo-controlled studies that evaluated the safety and pharmacokinetics of single escalating intravenous doses of lubeluzole. The first dose of study m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::976b734fda054376b7b92b70c8d1d3e1
https://pubmed.ncbi.nlm.nih.gov/9444444
https://pubmed.ncbi.nlm.nih.gov/9444444
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.